The ESN360 Academy is a non-promotional medical education programme funded and organised by Angelini Pharma UK-I for UK and Ireland epilepsy specialist nurses (ESNs). In 2023 we are holding a 2-day event in London focused on providing education; training; and practical guidance for ESNs across the UK and Ireland. The agenda will feature case-study presentations from delegates; expert Q&A sessions; plenary presentations; and a choice of practical workshops; covering key topics including supporting vulnerable populations with epilepsy; optimising epilepsy care for women of childbearing potential; reducing mortality risk in epilepsy and the benefits and pitfalls of virtual and face-to-face care.
At Angelini Pharma, we work every day to grow as a leading Pharma Company that makes a difference in patients’ life. We aim at becoming a leading European player, offering people, patients and their beloved ones new medicines and solutions to achieve better health outcomes and higher quality of life.
We make our vision real through robust pipeline growth, strong collaborations with best-in-class Research Institutes and valuable partnerships with our strategic allies.
We pledge to successfully develop distinctive treatments for CNS, Mental Health disorders, Rare Diseases while preserving our leading position in the Consumer Health segment.
